Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OXALIPLATIN Cause Reactive capillary endothelial proliferation? 11 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Reactive capillary endothelial proliferation have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.0% of all adverse event reports for OXALIPLATIN.

11
Reports of Reactive capillary endothelial proliferation with OXALIPLATIN
0.0%
of all OXALIPLATIN reports
2
Deaths
2
Hospitalizations

How Dangerous Is Reactive capillary endothelial proliferation From OXALIPLATIN?

Of the 11 reports, 2 (18.2%) resulted in death, 2 (18.2%) required hospitalization.

Is Reactive capillary endothelial proliferation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 11 reports have been filed with the FAERS database.

What Other Side Effects Does OXALIPLATIN Cause?

Diarrhoea (4,963) Nausea (4,250) Neuropathy peripheral (3,662) Off label use (3,603) Neutropenia (3,391) Vomiting (3,383) Disease progression (3,370) Thrombocytopenia (2,886) Dyspnoea (2,779) Pyrexia (2,269)

What Other Drugs Cause Reactive capillary endothelial proliferation?

CAMRELIZUMAB (41) CAPECITABINE (19) CISPLATIN (19) DOCETAXEL\DOCETAXEL ANHYDROUS (17) ATEZOLIZUMAB (10) BEVACIZUMAB (10) PEMBROLIZUMAB (7) SINTILIMAB (7) TORIPALIMAB (6) LENVATINIB (5)

Which OXALIPLATIN Alternatives Have Lower Reactive capillary endothelial proliferation Risk?

OXALIPLATIN vs OXAPROZIN OXALIPLATIN vs OXAZEPAM OXALIPLATIN vs OXCARBAZEPINE OXALIPLATIN vs OXITRIPTAN OXALIPLATIN vs OXOMEMAZINE

Related Pages

OXALIPLATIN Full Profile All Reactive capillary endothelial proliferation Reports All Drugs Causing Reactive capillary endothelial proliferation OXALIPLATIN Demographics